Relief Therapeutics Holding AG (RLFTF)

[elllk]

VANBIT, THIS MANAGEMENT DID ACHIEVE THE FEAT OF IDENTIFYING THIS REMARKABLE DRUG AND ITS POTENTIAL. THEY ALSO WERE FAIRLY EPT IN PUTTING TOGETHER A SERIES OF PARTNERSHIPS IN PURSUIT OF PROVIDING EFFECTIVE AND EFFICIENT DISTRIBUTION OF THE DRUG. THERE IS, AS USUAL, SOME WIGGLE WIGGLE IN CONSOLIDATING THESE PARTNERSHIPS INTO A SMOOTHLY RUNNING TEAM. THE GREED YOU ATTACK SHOULD MOTIVATE THEM TO OVERCOME THESE ISSUES. THEY ARE AWARE, AS YOU ARE NOT, THAT PUBLIC AWARENESS NOW WILL NOT MATTER WITHOUT AN FDA EUA AND THEN NDA. THEY ARE FOCUSING THEIR RESOURCES AND EFFORT ON DEALING WITH THE FDA. YOU WOULD PREFER THEM TO BE FOCUSING ALL THEIR MONEY, RESOURCES AND EFFORT ON PROMOTING PUBLIC AWARENESS. THAT WILL HAVE NO IMPACT ON THE FDA. ON THE OTHER HAND, IF THE FDA GIVES THE GREEN LIGHT THEN PUBLIC AWARENESS WILL BE DRAMATICALLY ACHIEVED OVER NIGHT WITHOUT THROWING UNAVAILABLE MONEY OR EFFORT INTO IT AT THE WRONG TIME. ONCE THAT HAPPENS MONEY WILL ALSO BECOME AVAILABLE TO CONTINUE BUILDING AN EFFECTIVE TEAM AND TO INCREASE THE DEVELOPING PUBLIC AWARENESS. THEY CAN'T CURRENTLY DO THE LATTER AND DON'T NEED TO NOW. YOUR APPROACH WOULD DRASTICALLY TAKE AWAY FROM WHERE THEY NEED TO BE PUTTING THEIR TIME, EFFORT AND RESOURCES RIGHT NOW TO LAY THE GROUND WORK FOR A DRAMATIC COMPANY. IT WOULD DAMAGE THE MOST IMPORTANT PART OF THEIR EFFORT AND CREATE WASTEFUL, UNNECESSARY AND MISDIRECTED EFFORT. YOU HAVE DRIVEN YOURSELF INTO A FAILED PERSPECTIVE.